J&J, Roche come out on top in S&P ratings of strongest pharma companies

he modern architecture of business center of Johnson and Johnson, Allschwil

yuelan

Johnson & Johnson (NYSE:JNJ) and Roche (OTCQX:RHHBY) are the strongest pharmaceutical companies, based on having the lowest business and financial risks among large drugmakers, according to a new S&P Global report.

J&J and Roche scored particularly well, respectively, in terms of scale

The report also listed the therapeutic areas with the largest seven-year compound annual growth rates going forward. They are gastro-intestinal (16.6%), dermatology (13.5%), oncology (9.8%), and cardiovascular (9.4%)

More on Johnson & Johnson, Roche

Leave a Reply

Your email address will not be published. Required fields are marked *